ANI Pharmaceuticals Expands Injectable Portfolio with Distribution Agreement for FDA Approved Injectable Product
ANI Pharmaceuticals, Inc. (ANIP)
Last ani pharmaceuticals, inc. earnings: 2/27 08:30 am
Check Earnings Report
US:NASDAQ Investor Relations:
anipharmaceuticals.com/investors_corporate_profile.php
Company Research
Source: PR Newswire
BAUDETTE, Minn., April 15, 2019 /PRNewswire/ -- ANI Pharmaceuticals, Inc. ("ANI" or the "Company") (Nasdaq: ANIP) today announced that it has entered into a Distribution Agreement with a U.S. based injectable manufacturer to commercialize a unique specialty injectable product. Key terms of the 10-year Agreement include cumulative milestones of up to $2M, payable by ANI. Upon launch, ANI will receive a 50% share of net profits generated from product revenues. The product, for which there are currently no other generics commercially available, recently received FDA approval. The product will be commercialized in the ANI label.ANI's President and CEO, Arthur S. Przybyl, commented, "With today's announcement we have added a second specialty injectable product to our pipeline, the first product being Cortrophin Gel. We are excited to further expand into injectable dosage form drug products. We believe injectables represent future growth opportunities for ANI and as such we intend to pursu
Show less
Read more
Impact Snapshot
Event Time:
ANIP
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
---|---|---|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
Last Price | ||
VWAP | ||
High:
|
Max Up |
High:
|
Low:
|
Max Down |
Low:
|
%
|
Post news range |
%
|
|
Price change |
|
|
Price Change Percentage |
|
|
S&P 500 (SPX) |
|
%
|
Volume ratio |
%
|
Volume | ||
Ticks | ||
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
ANIP alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
ANIP alerts
High impacting ANI Pharmaceuticals, Inc. news events
Weekly update
A roundup of the hottest topics
ANIP
News
- ANI Pharmaceuticals (ANIP) Rises Yet Lags Behind Market: Some Facts Worth Knowing [Yahoo! Finance]Yahoo! Finance
- ANI Pharmaceuticals Announces the Launch of Levofloxacin Oral Solution, USP [Yahoo! Finance]Yahoo! Finance
- ANI Pharmaceuticals Announces the Launch of Levofloxacin Oral Solution, USPGlobeNewswire
- ANI Pharmaceuticals, Inc. (ANIP) Hits Fresh High: Is There Still Room to Run? [Yahoo! Finance]Yahoo! Finance
- ANI Pharmaceuticals (ANIP) Outpaces Stock Market Gains: What You Should Know [Yahoo! Finance]Yahoo! Finance
ANIP
Earnings
- 2/29/24 - Beat
ANIP
Sec Filings
- 3/25/24 - Form 4
- 3/25/24 - Form 4
- 3/25/24 - Form 4
- ANIP's page on the SEC website